Lisdexamfetamine Dimesylate 67651-0387
Product NDC
67651-0387- Manufacturer
- Patheon Pharmaceuticals Inc.
- Dosage Form
- Capsule
- Product Type
- Drug For Further Processing
- DEA Schedule
- Schedule CII
- Marketing Start
- February 19, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 30 mg/1 |
Packaging Options(1)
32000 CAPSULE in 1 DRUM (67651-0387-0)